Thames Cancer Registry, Kings College London, 42 Weston Street, London, UK.
Br J Cancer. 2009 Dec 3;101 Suppl 2(Suppl 2):S110-4. doi: 10.1038/sj.bjc.6605400.
This paper provides a one-page visual summary of the previously published relative survival estimates for 42 types of cancers in 23 countries in Europe.
The cancer patients in these analyses were 15 years or older at the time of their diagnosis in the period 1995-1999. Follow-up was to the end of 2003 and relative survival estimates were computed by the cohort method.
The analysis of 1-year survival had good discriminatory power and visibly separated a group of countries with consistently high survival estimates (Switzerland, France, Sweden, Belgium and Italy) and another group of countries with lower estimates (Poland, Czech Republic, Ireland, Denmark and United Kingdom-Northern Ireland). After the first year, there was less variation between the countries.
To more fully understand the UK situation, a rational comparison would select countries with data-quality, prosperity and healthcare systems that are similar to the United Kingdom. In otherwise comparable populations, a pronounced difference in 1-year survival is most likely to be due to variation in a strong prognostic factor, which exerts its effect in the short term. A likely explanation for the short-term survival deficit in the United Kingdom compared with the Nordic countries is a less favourable stage distribution in the United Kingdom. However, the present superficial analysis does not exclude possible functions for other factors relating to the organisation and quality of cancer care services.
本文提供了一份欧洲 23 个国家 42 种癌症的相对生存率的单页可视化总结，此前已发表。
这些分析中的癌症患者在诊断时年龄为 15 岁或以上，诊断时间在 1995-1999 年期间。随访至 2003 年底，相对生存率采用队列法计算。
1 年生存率的分析具有良好的区分能力，明显区分了一组生存率一直较高的国家（瑞士、法国、瑞典、比利时和意大利）和另一组生存率较低的国家（波兰、捷克共和国、爱尔兰、丹麦和英国北爱尔兰）。在第一年之后，各国之间的差异较小。
为了更全面地了解英国的情况，进行合理比较时应选择数据质量、繁荣程度和医疗保健系统与英国相似的国家。在其他方面可比的人群中，1 年生存率的显著差异很可能是由于预后因素的差异，这些因素在短期内发挥作用。与北欧国家相比，英国在短期生存率方面的不足可能是由于英国的分期分布不利。然而，目前的表面分析并不能排除与癌症护理服务的组织和质量有关的其他因素的可能作用。
